Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara C Kahl

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
International Journal of Medical Microbiology : IJMM|September 17, 2010
Impact of Staphylococcus aureus on the pathogenesis of chronic cystic fibrosis lung diseaseBarbara C Kahl
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|June 1, 2013
Small colony variants (SCVs) of Staphylococcus aureus--a bacterial survival strategyBarbara C Kahl
Journal of Clinical Microbiology|January 7, 2014
Assessment of microbiological diagnostic procedures for respiratory specimens from cystic fibrosis patients in German laboratories by use of a questionnaireLaura Häfner, Georg Peters, Barbara C Kahl
Clinical Microbiology Reviews|March 11, 2016
Clinical Significance and Pathogenesis of Staphylococcal Small Colony Variants in Persistent InfectionsBarbara C Kahl, Karsten Becker, Bettina Löffler
Veterinary Microbiology|December 9, 2015
The clinical impact of livestock-associated methicillin-resistant Staphylococcus aureus of the clonal complex 398 for humansKarsten Becker, Britta Ballhausen, Barbara C Kahl, et al.
Pathogens (Basel, Switzerland)|September 28, 2021
<i>Staphylococcus aureus</i> and Cystic Fibrosis-A Close Relationship. What Can We Learn from Sequencing Studies?Christine Rumpf, Jonas Lange, Bianca Schwartbeck, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|May 5, 2022
Susceptibility of <i>Burkholderia cepacia</i> Complex to Ceftazidime/Avibactam and Standard Drugs of Treatment for Cystic Fibrosis PatientsFrieder Schaumburg, Evgeny A Idelevich, Alexander Mellmann, et al.
Frontiers in Microbiology|April 14, 2022
Role of Efflux in Antibiotic Resistance of <i>Achromobacter xylosoxidans</i> and <i>Achromobacter insuavis</i> Isolates From Patients With Cystic FibrosisHussein Chalhoub, Stefanie Kampmeier, Barbara C Kahl, et al.
Journal of Clinical Medicine|April 3, 2021
Correlations of Host and Bacterial Characteristics with Clinical Parameters and Survival in <i>Staphylococcus aureus</i> BacteremiaHannah Wächter, Erdal Yörük, Karsten Becker, et al.
Journal of Clinical Microbiology|January 7, 2005
Variation of the polymorphic region X of the protein A gene during persistent airway infection of cystic fibrosis patients reflects two independent mechanisms of genetic change in Staphylococcus aureusBarbara C Kahl, Alexander Mellmann, Susanne Deiwick, et al.
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
International Journal of Medical Microbiology : IJMM|September 17, 2010
Impact of Staphylococcus aureus on the pathogenesis of chronic cystic fibrosis lung diseaseBarbara C Kahl
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|June 1, 2013
Small colony variants (SCVs) of Staphylococcus aureus--a bacterial survival strategyBarbara C Kahl
Journal of Clinical Microbiology|January 7, 2014
Assessment of microbiological diagnostic procedures for respiratory specimens from cystic fibrosis patients in German laboratories by use of a questionnaireLaura Häfner, Georg Peters, Barbara C Kahl
Clinical Microbiology Reviews|March 11, 2016
Clinical Significance and Pathogenesis of Staphylococcal Small Colony Variants in Persistent InfectionsBarbara C Kahl, Karsten Becker, Bettina Löffler
Veterinary Microbiology|December 9, 2015
The clinical impact of livestock-associated methicillin-resistant Staphylococcus aureus of the clonal complex 398 for humansKarsten Becker, Britta Ballhausen, Barbara C Kahl, et al.
Pathogens (Basel, Switzerland)|September 28, 2021
<i>Staphylococcus aureus</i> and Cystic Fibrosis-A Close Relationship. What Can We Learn from Sequencing Studies?Christine Rumpf, Jonas Lange, Bianca Schwartbeck, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|May 5, 2022
Susceptibility of <i>Burkholderia cepacia</i> Complex to Ceftazidime/Avibactam and Standard Drugs of Treatment for Cystic Fibrosis PatientsFrieder Schaumburg, Evgeny A Idelevich, Alexander Mellmann, et al.
Frontiers in Microbiology|April 14, 2022
Role of Efflux in Antibiotic Resistance of <i>Achromobacter xylosoxidans</i> and <i>Achromobacter insuavis</i> Isolates From Patients With Cystic FibrosisHussein Chalhoub, Stefanie Kampmeier, Barbara C Kahl, et al.
Journal of Clinical Medicine|April 3, 2021
Correlations of Host and Bacterial Characteristics with Clinical Parameters and Survival in <i>Staphylococcus aureus</i> BacteremiaHannah Wächter, Erdal Yörük, Karsten Becker, et al.
Journal of Clinical Microbiology|January 7, 2005
Variation of the polymorphic region X of the protein A gene during persistent airway infection of cystic fibrosis patients reflects two independent mechanisms of genetic change in Staphylococcus aureusBarbara C Kahl, Alexander Mellmann, Susanne Deiwick, et al.
Pageof 9